Harry W. Diehl first discovered the predecessor of CMO capsules in 1971 at the National Institutes of Health.

That predecessor was cetylmyristoleate. Unfortunately, Mr. Diehl was unable to get his project funded and slowly carried on at his own expense in his own home laboratory. Eventually, in March 1994, Harry Diehl’s report about injectable cetylmyristoleate was published in The Journal of Pharmaceutical Sciences. In the report he expressed his hope that other studies would be conducted, “particularly, more extensive tests of cetylmyristoleate analogues”.

In late 1994 the San Diego Clinic research staff did exactly what the researcher had hoped for. They developed an orally administered dietary supplement. The dietary supplement is an analogue with the name CMO. The San Diego Clinic did the first clinical study on CMO and its director, Dr. Len Sands, was the first person to take CMO.

In December 1995, CMO was introduced in Nevada to the medical community at the National Medical Conference on Aging. CMO became a star of the conference, resulting ultimately in hundreds of doctors prescribing CMO for their patients.

In February 1996, CMO became available to the public. Already, several books have been written about CMO and its astonishing effectiveness. It took twenty-five years for CMO to finish its long journey from discovery to use by the public.

In March 2000,  CMO+   became the new standard for CMO products with  proprietary digestive enzymes built into each capsule. Now sold in combination with the fast acting homeopathic arthritis pain reliever, HPR, the beneficial results experienced by users of CMO+HPR are reported as being faster and better than any previous formulations.